Nevro (NVRO) Competitors

Nevro logo
$5.72 0.00 (0.00%)
Closing price 02/12/2025 03:59 PM Eastern
Extended Trading
$5.72 0.00 (0.00%)
As of 02/12/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NVRO vs. SIBN, TMCI, KIDS, DCTH, SMLR, CLPT, TCMD, NNOX, NPCE, and ZIMV

Should you be buying Nevro stock or one of its competitors? The main competitors of Nevro include SI-BONE (SIBN), Treace Medical Concepts (TMCI), OrthoPediatrics (KIDS), Delcath Systems (DCTH), Semler Scientific (SMLR), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), Nano-X Imaging (NNOX), NeuroPace (NPCE), and ZimVie (ZIMV). These companies are all part of the "medical equipment" industry.

Nevro vs.

SI-BONE (NASDAQ:SIBN) and Nevro (NYSE:NVRO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, community ranking, media sentiment, profitability, risk, institutional ownership and analyst recommendations.

Nevro received 335 more outperform votes than SI-BONE when rated by MarketBeat users. However, 68.42% of users gave SI-BONE an outperform vote while only 63.00% of users gave Nevro an outperform vote.

CompanyUnderperformOutperform
SI-BONEOutperform Votes
169
68.42%
Underperform Votes
78
31.58%
NevroOutperform Votes
504
63.00%
Underperform Votes
296
37.00%

SI-BONE currently has a consensus target price of $23.00, indicating a potential upside of 41.80%. Nevro has a consensus target price of $6.43, indicating a potential upside of 12.33%. Given SI-BONE's stronger consensus rating and higher probable upside, equities research analysts plainly believe SI-BONE is more favorable than Nevro.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SI-BONE
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00
Nevro
2 Sell rating(s)
11 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.93

SI-BONE has higher earnings, but lower revenue than Nevro. SI-BONE is trading at a lower price-to-earnings ratio than Nevro, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SI-BONE$138.89M4.90-$43.34M-$0.92-17.63
Nevro$425.17M0.50-$92.21M-$1.89-3.03

SI-BONE has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Comparatively, Nevro has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500.

In the previous week, Nevro had 22 more articles in the media than SI-BONE. MarketBeat recorded 25 mentions for Nevro and 3 mentions for SI-BONE. Nevro's average media sentiment score of 0.51 beat SI-BONE's score of 0.14 indicating that Nevro is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SI-BONE
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Nevro
4 Very Positive mention(s)
3 Positive mention(s)
14 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Nevro has a net margin of -16.54% compared to SI-BONE's net margin of -23.82%. SI-BONE's return on equity of -22.51% beat Nevro's return on equity.

Company Net Margins Return on Equity Return on Assets
SI-BONE-23.82% -22.51% -16.53%
Nevro -16.54%-23.52%-10.83%

98.1% of SI-BONE shares are held by institutional investors. Comparatively, 95.5% of Nevro shares are held by institutional investors. 3.9% of SI-BONE shares are held by insiders. Comparatively, 3.2% of Nevro shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

SI-BONE beats Nevro on 11 of the 18 factors compared between the two stocks.

Get Nevro News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVRO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVRO vs. The Competition

MetricNevroSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$214.33M$4.67B$5.66B$20.22B
Dividend YieldN/A51.43%5.31%3.67%
P/E Ratio-3.0325.0090.3644.90
Price / Sales0.5055.761,035.7316.23
Price / CashN/A50.3946.0920.34
Price / Book0.716.925.135.73
Net Income-$92.21M$87.36M$113.24M$1.00B
7 Day Performance13.83%-2.60%-0.99%-1.10%
1 Month Performance74.39%1.20%4.19%3.51%
1 Year Performance-67.13%19.03%21.68%15.05%

Nevro Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVRO
Nevro
2.0129 of 5 stars
$5.72
flat
$6.43
+12.3%
-67.1%$214.33M$425.17M-3.031,215Upcoming Earnings
Analyst Upgrade
SIBN
SI-BONE
4.3088 of 5 stars
$17.02
+1.6%
$23.00
+35.1%
-24.8%$713.79M$157.04M-18.50350Gap Down
TMCI
Treace Medical Concepts
0.8642 of 5 stars
$9.69
-3.6%
$8.98
-7.3%
-38.1%$603.69M$187.12M-9.79250Gap Down
KIDS
OrthoPediatrics
4.5849 of 5 stars
$24.05
+0.2%
$39.00
+62.2%
-14.7%$582.49M$148.73M-19.55200Short Interest ↓
DCTH
Delcath Systems
3.1224 of 5 stars
$15.45
-1.0%
$22.25
+44.0%
+229.5%$493.94M$2.07M-11.4460Short Interest ↑
Positive News
Gap Down
SMLR
Semler Scientific
2.9301 of 5 stars
$50.46
-2.9%
$71.00
+40.7%
-0.9%$467.61M$58.94M24.61120Short Interest ↑
Positive News
Gap Down
CLPT
ClearPoint Neuro
1.5884 of 5 stars
$16.95
-2.9%
$19.67
+16.0%
+140.7%$467.48M$23.95M-24.57110Short Interest ↓
News Coverage
Gap Down
TCMD
Tactile Systems Technology
3.6335 of 5 stars
$17.34
-1.0%
$23.00
+32.6%
+7.8%$416.16M$274.42M26.68980Upcoming Earnings
NNOX
Nano-X Imaging
2.6882 of 5 stars
$7.08
-2.7%
$17.50
+147.2%
+5.3%$409.08M$9.90M-8.33190
NPCE
NeuroPace
3.3389 of 5 stars
$13.61
-1.1%
$14.80
+8.7%
-24.5%$406.26M$65.42M-13.61170Short Interest ↓
ZIMV
ZimVie
2.5202 of 5 stars
$13.74
-0.7%
$19.50
+41.9%
-33.9%$379.22M$457.43M-1.052,600

Related Companies and Tools


This page (NYSE:NVRO) was last updated on 2/13/2025 by MarketBeat.com Staff
From Our Partners